Long-‐life supplementation with atenolol…
273
55. Hybertson, B.M.; Gao, B.; Bose, S.K.; McCord; J.M.
Oxidative stress in health and disease:
The therapeutic potential of Nrf2 activation.
Molecular Aspects of Medicine
2011;
32
, 234–
246 56. Dogan, S.A.; Trifunovic, A. Modelling Mitochondrial Dysfunction in Mice.
Physiol. Res
. 2011;
60
(Suppl. 1), S61-‐S70
57. Perez-‐Campo, R.; López-‐Torres, M.; Cadenas, S.; Rojas, C.; Barja, G. The rate of free radical
production as a determinant of the rate of aging: evidence from the comparative approach
.
J Comp Physiol B
1998;
168
, 149–158
58. Page, M.M.; Stuart J.A. Activities of DNA base excision repair enzymes in liver and brain
correlate with body mass, but not with lifespan,
Age
, 2011;
34
, 1195-‐209.
59. Barja, G. Free radicals and aging.
Trends in Neurosci
2004;
27
, 595-‐600
60. Cockcroft, J.R.; Pedersen, M.D. b-‐Blockade: Benefits Beyond Blood Pressure Reduction?
The
Journal of Clinical Hypertension.
2012;
14
, 112-‐120
61. Bangalore, S.; Sawhney, S.; Messerli, F.H. Relation of beta-‐blocker-‐induced heart rate
lowering and cardioprotection in hypertension.
J. Amer. College of Cardiol.
2008;
52
, 1482-‐
1489.
62. Cucherat, M.; Borer, J.S. Reduction of Resting Heart Rate With Antianginal Drugs: Review
and Meta-‐Analysis.
American Journal of Therapeutics
2012;
19
, 269–280
63. London, G.M.; Asmar, R.G.; O’Rourke, M.F.; Safar M.E. Mechanism(s) of Selective Systolic
Blood Pressure Reduction After a Low-‐Dose Combination of Perindopril/Indapamide in
Hypertensive Subjects: Comparison With Atenolol.
Journal of the American College of
Cardiology.
2004,
43
, 92-‐99.
